HCPCS Range Cancer and Vision Associated Drugs

• 1 Injection, trastuzumab-dttb, biosimilar, (Ontruzant), 10 mg ( Q5112 )

• 2 Injection, trastuzumab-pkrb, biosimilar, (Herzuma), 10 mg ( Q5113 )

• 3 Injection, Trastuzumab-dkst, biosimilar, (Ogivri), 10 mg ( Q5114 )

• 4 Injection, rituximab-abbs, biosimilar, (Truxima), 10 mg ( Q5115 )

• 5 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg ( Q5116 )

• 6 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg ( Q5117 )

• 7 Injection, bevacizumab-bvzr, biosimilar, (Zirabev), 10 mg ( Q5118 )

• 8 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg ( Q5119 )

• 9 Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg ( Q5120 )

• 10 Injection, infliximab-axxq, biosimilar, (avsola), 10 mg ( Q5121 )

• 11 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg ( Q5122 )

• 12 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg ( Q5123 )

• 13 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg ( Q5124 )

• 14 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram ( Q5125 )

• 15 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg ( Q5126 )

• 16 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg ( Q5127 )

• 17 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg ( Q5128 )

• 18 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg ( Q5129 )

• 19 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg ( Q5130 )

• 20 Injection, adalimumab-aacf (idacio), biosimilar, 20 mg ( Q5131 )

• 21 Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg ( Q5132 )

• 22 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg ( Q5133 )

• 23 Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg ( Q5134 )